With Pandemic in Rearview Mirror, BriaCell Charges Ahead with Cancer Immunotherapy By Mark TerryApril 25, 2023 Many biopharma companies had to place their clinical trials on hold during the first [….]
A big name in the medical field is joining the board of Galen Robotics, a biotech startup in Baltimore.
Robert Langer, one of the co-founders of pharmaceutical giant Moderna, said the Pigtown company’s robotic arm could change the way surgeries are done.
“I thought it was really cool and I think it could help a lot of people,” Langer said of Galen. “They’re bringing robotic surgery into areas that could make a huge impact.”
Langer, an engineer, has helped found dozens of biotech startups and is currently a professor at the Massachusetts Institute of Technology.
Moderna Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based therapeutics, today announced that the two companies have entered into a strategic collaboration agreement to discover, develop and commercialize in vivo engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for the treatment of cancer.
Global COVID-19 cases have been spiking in Europe and the U.S. as the predicted second wave is hitting communities hard, applying new pressure on hospital capacity and forcing local and state governments to once again tighten restrictions.
